Info
🌱 來自: Huppert’s Notes
Neutropenic Fever🚧 施工中
Neutropenic Fever
• [Guideline] Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011;52(4):e56–93.
- This clinical practice guideline from the IDSA is intended to guide the use of antimicrobial agents in patients with cancer who develop fever in the setting of chemotherapy-induced neutropenia. It includes the risk stratification algorithm to determine which patients are at high- and low-risk of complications.
• [Guideline] Outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology and infectious diseases society of America clinical practice guideline update summary*. J Oncol Pract* 2018;14(4):250–255.
- This guideline seeks to answer questions around which patients with fever and neutropenia can be managed as outpatients. It also includes recommendations on the basic workup of febrile neutropenia.
• Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: Current epidemiology and clinical impact. Curr Opin Infect Dis 2014;27(2):200–210.
- A review that examines recent trends in epidemiology and antimicrobial resistance in Gram-negative infections in neutropenic cancer patients. It pays particular attention to the impact of antimicrobial resistance on the outcomes of severe infections caused by these organisms.